If you're looking to brush up on your knowledge before watching Apple TV+’s ‘Franklin’ check out my free Coursera course and take a deeper look at the kind of person he was – curious, amenable, and brilliant.
coursera.org/learn/benjamin…

I spoke with Carla K. Johnson about the U.S. FDA's accelerated approval program for cancer drugs and how we balance early access with rigorous testing. Read ⬇️
apnews.com/article/cancer…

New @Truveta Research, in partnership with Zeke Emanuel, shows less than 1% of eligible older Americans have a current Rx for an anti-obesity medication. Will be interesting to see how this evolves with Medicare now covering Wegovy for heart problems. tr.vet/3TGi3fC

One thing people always seem to remember about me is an article I wrote nearly a decade ago on why I plan to deny medical treatment after 75. Tonight I’m looking forward to talking all things longevity with Ravi B. Parikh Jason Karlawish Stephanie Stahl!
eventbrite.com/e/lets-talk-lo…

Join us next Friday, March 22 for the 2024 Charles C. Leighton, MD Memorial Lecture presented by LDI Fellow Ezekiel J. Emanuel (Zeke Emanuel)!

This event is open to Penn affiliates with registration. See details here:
ldi.upenn.edu/events/charles…

North Carolina said that removing coverage of GLP-1s for people who are obese is “cost-effective.”

I explain why it's in fact MORE cost-effective to cover the people who need GLP-1s in Axios with Tina Reed.

axios.com/2024/03/04/a-f…

Twitter friends–if you're interested in learning more about my upcoming projects, my opinions on GLP-1s, bioethics, and Ben Franklin (just to name a few), join me over on LinkedIn where I’ll be posting more regularly.

linkedin.com/in/zeke-emanue…

While GLP-1s aren't the sole solution to the US obesity epidemic, if we have effective treatments they must be utilized. In my The Wall Street Journal piece, I propose NC health systems: 1. Cut drug costs💊💰 2. Prioritize drug use for maximum benefit 3. Tax the cause of obesity--processed foods

The Perelman School of Medicine has received a $2.1M grant from PolyBio to expand #longCOVID research. The funding will support studies focusing on SARS-CoV-2 persistence in the gut, in addition to work defining long COVID immune responses. spr.ly/6019X6tEF

Cases of measles are rising and guess what? WE KNOW how to prevent it. We must do more to address falling childhood vaccination rates for #measles and other vaccine-preventable diseases.

#childhoodvaccinations #publichealth #measles outbreak

📅SAVE THE DATE: Join us on Friday, March 22 for the 2024 Charles C. Leighton, MD Memorial Lecture presented by LDI Fellow Ezekiel J. Emanuel (Zeke Emanuel)!

This event is open to Penn affiliates with registration. See details here:
ldi.upenn.edu/events/charles…